Sponsor or institution
Clinical trials and research at YolTech Therapeutics Co., Ltd
As of November 12, 2026, Find a Trial lists 2 clinical trials run by YolTech Therapeutics Co., Ltd that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Single-dose test of YOLT-203 in PH1 patients
This study tests a single dose of YOLT-203 in people with Primary Hyperoxaluria Type 1 to see if it is safe and whether it lowers urinary oxalate.
-
YOLT-203 for Primary Hyperoxaluria Type 1: 6+ years old to adults
This study tests YOLT-203 versus placebo in children and adults with Primary Hyperoxaluria Type 1 to see if it safely reduces oxalate and improves symptoms.
Quick answers
How many clinical trials run by YolTech Therapeutics Co., Ltd are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.